Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Ann. hepatol ; 16(2): 297-303, Mar.-Apr. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-887236

RESUMO

ABSTRACT Introduction and aim. The inability to distinguish cancer (CSCs) from normal stem cells (NSCs) has hindered attempts to identify safer, more effective therapies for hepatocellular carcinoma (HCC). The aim of this study was to document and compare cell membrane potential differences (PDs) of CSCs and NSCs derived from human HCC and healthy livers respectively and determine whether altered GABAergic innervation could explain the differences. Material and methods. Epithelial cell adhesion molecule (EpCAM) positive stem cells were isolated from human liver tissues by magnetic bead separations. Cellular PDs were recorded by microelectrode impalement of freshly isolated cells. GABAA receptor subunit expression was documented by reverse transcriptase polymerase chain reaction (RT-PCR) and immunofluorescence. Results. CSCs were significantly depolarized (-7.0 ± 1.3 mV) relative to NSCs (-23.0 ± 1.4 mV, p < 0.01). The depolarized state was associated with different GABAA receptor subunit expression profiles wherein phasic transmission, represented by GAGAA α3 subunit expression, was prevalent in CSCs while tonic transmission, represented by GABAA α6 subunit expression, prevailed in NSCs. In addition, GABAA subunits α3, β3, γ3 and δ were strongly expressed in CSCs while GABAA π expression was dominant in NSCs. CSCs and NSCs responded similarly to GABAA receptor agonists (ΔPD: 12.5 ± 1.2 mV and 11.0 ± 3.5 mV respectively). Conclusion. The results of this study indicate that CSCs are significantly depolarized relative to NSCs and these differences are associated with differences in GABAA receptor subunit expression. Together they provide new insights into the pathogenesis and possible treatment of human HCC.


Assuntos
Humanos , Células-Tronco Neoplásicas/metabolismo , Receptores de GABA-A/metabolismo , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/metabolismo , Agonistas de Receptores de GABA-A/farmacologia , Molécula de Adesão da Célula Epitelial/metabolismo , Fígado/citologia , Neoplasias Hepáticas/metabolismo , Fenótipo , Células-Tronco/efeitos dos fármacos , Células-Tronco Neoplásicas/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Biomarcadores/metabolismo , Imunofluorescência , Separação Imunomagnética , Receptores de GABA-A/efeitos dos fármacos , Receptores de GABA-A/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Subunidades Proteicas , Neoplasias Hepáticas/genética , Potenciais da Membrana/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA